Maxim S Petrov1. 1. Department of Surgery, The University of Auckland, Private Bag 92019, Auckalnd 1142, New Zealand. max.petrov@gmail.com
Abstract
PURPOSE OF REVIEW: This review presents new evidence on the role of oxidative stress and antioxidant status in acute and chronic pancreatitis published in the last year. RECENT FINDINGS: In-vitro studies showed that protein phosphatases may play an important role in the interaction between reactive oxygen species and proinflammatory cytokines in acute pancreatitis. In-vivo studies found that several natural compounds ameliorate oxidative stress and, therefore, have therapeutic potential. In the domain of clinical studies, the major development is the first double-blind placebo-controlled randomized trial that showed effectiveness of oral antioxidant supplementation (organic selenium, ascorbic acid, alpha-tocopherol, beta-carotene, and methionine) in relieving pain in patients with chronic pancreatitis. The developments in clinical studies on acute pancreatitis are less spectacular and mainly limited to evaluation of different markers of oxidative stress and antioxidant status in the course of disease. SUMMARY: A significant advance has been made in the arena of research in chronic, but not acute, pancreatitis. There is now solid evidence to justify the use of oral antioxidants in the treatment of patients with chronic pancreatitis. The progress in clinical research on antioxidants in acute pancreatitis is hampered by several factors, including suboptimal classification of acute pancreatitis and route of administration used in previous studies.
PURPOSE OF REVIEW: This review presents new evidence on the role of oxidative stress and antioxidant status in acute and chronic pancreatitis published in the last year. RECENT FINDINGS: In-vitro studies showed that protein phosphatases may play an important role in the interaction between reactive oxygen species and proinflammatory cytokines in acute pancreatitis. In-vivo studies found that several natural compounds ameliorate oxidative stress and, therefore, have therapeutic potential. In the domain of clinical studies, the major development is the first double-blind placebo-controlled randomized trial that showed effectiveness of oral antioxidant supplementation (organic selenium, ascorbic acid, alpha-tocopherol, beta-carotene, and methionine) in relieving pain in patients with chronic pancreatitis. The developments in clinical studies on acute pancreatitis are less spectacular and mainly limited to evaluation of different markers of oxidative stress and antioxidant status in the course of disease. SUMMARY: A significant advance has been made in the arena of research in chronic, but not acute, pancreatitis. There is now solid evidence to justify the use of oral antioxidants in the treatment of patients with chronic pancreatitis. The progress in clinical research on antioxidants in acute pancreatitis is hampered by several factors, including suboptimal classification of acute pancreatitis and route of administration used in previous studies.
Authors: Ahmed Bettaieb; Samah Chahed; Santana Bachaalany; Stephen Griffey; Bruce D Hammock; Fawaz G Haj Journal: Mol Pharmacol Date: 2015-05-20 Impact factor: 4.436
Authors: Ibrahim Akyazi; Evren Eraslan; Ahmet Gülçubuk; Elif Ergül Ekiz; Zeynep L Cırakli; Damla Haktanir; Deniz Aktaran Bala; Mete Ozkurt; Erdal Matur; Mukaddes Ozcan Journal: World J Gastroenterol Date: 2013-05-21 Impact factor: 5.742
Authors: Murray Korc; Christie Y Jeon; Mouad Edderkaoui; Stephen J Pandol; Maxim S Petrov Journal: Best Pract Res Clin Gastroenterol Date: 2017-09-06 Impact factor: 3.043
Authors: Michael Chvanov; Wei Huang; Tao Jin; Li Wen; Jane Armstrong; Vicky Elliot; Ben Alston; Alex Burdyga; David N Criddle; Robert Sutton; Alexei V Tepikin Journal: Antioxid Redox Signal Date: 2014-04-30 Impact factor: 8.401
Authors: Amy Y Xiao; Marianne L Tan; Maria N Plana; Dhiraj Yadav; Javier Zamora; Maxim S Petrov Journal: Clin Transl Gastroenterol Date: 2018-10-04 Impact factor: 4.488